CPB
Packaged Foods · Consumer Defensive
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when CAMPBELL'S Co publishes a filing, an earnings call transcript or a press release.
Get CPB alertsCarrie Anderson is recorded as CFO at CAMPBELL'S Co (CPB). Earlier roles on record: CFO at Integra Lifesciences Holdings Corp (IART) until February 2, 2023. Integra Lifesciences Holdings Corp reported in an 8-K filed January 25, 2023 that Carrie Anderson resigned as Chief Financial Officer, effective February 2, 2023. The proxy statement of CAMPBELL'S Co reports total compensation of $3,787,050 for Carrie Anderson in fiscal 2025, including a base salary of $803,677. Disclosed compensation is on record for 6 fiscal years. Carrie Anderson has spoken on 21 earnings calls across 2 companies, most recently for CAMPBELL'S Co on September 3, 2025. Those appearances were for Integra Lifesciences Holdings Corp (IART) and CAMPBELL'S Co (CPB). CAMPBELL'S Co is classified in the Packaged Foods industry within the Consumer Defensive sector. Other companies whose calls Carrie Anderson spoke on are classified in the Healthcare sector. Other leadership on record at CAMPBELL'S Co includes Mick J. Beekhuizen (CEO and Board Member), Carrie L. Anderson (CFO), Todd E. Cunfer (CFO) and 7 others.
“On January 25, 2023, Carrie Anderson, Chief Financial Officer of Integra LifeSciences Holdings Corporation (the “Company”), notified the Company of her decision to resign, effective as of February 2, 2023, to pursue another professional opportunity.”
“Turning to our Q4 results, as Mick said earlier, our fourth quarter performance was slightly ahead of our expectations. As a reminder, our Q4 and full-year results include the contribution of an additional week in fiscal 2025.”
“As Mick said earlier, our third quarter performance exceeded our expectations. The overperformance in the quarter was primarily attributable to our meals and beverages division, which benefited from the timing of customer inventory orders.”
“Our second quarter adjusted EPS was in line with our expectations, despite the dynamic operating environment Mick discussed earlier.”
“Our first quarter results were generally in line with our expectations, with overperformance from Sovos Brands, and an earnings performance in line with expectations.”
“I'll begin with an overview of our fourth quarter, including continued strong performance from the Sovos Brands acquisition. Fourth quarter reported net sales were up 11%, driven by the contribution from Sovos.”
Start not stated–2023-02-02
CPB
Packaged Foods · Consumer Defensive
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | CAMPBELL'S Co (CPB) | CFO | $803,677 | $3,787,050 |
| 2024 | CAMPBELL'S Co (CPB) | CFO | $778,125 | $3,855,472 |
| 2023 | CAMPBELL'S Co (CPB) | CFO | $361,823 | $4,328,097 |
| 2023 | Integra Lifesciences Holdings Corp (IART) | Former Executive Vice President and Chief Financial Officer | $64,692 | $67,280 |
| 2022 | Integra Lifesciences Holdings Corp (IART) | Former Executive Vice President and Chief Financial Officer | $565,404 | $2,951,694 |
| 2021 | Integra Lifesciences Holdings Corp (IART) | Former Executive Vice President and Chief Financial Officer | $518,462 | $2,636,663 |
| 2020 | Integra Lifesciences Holdings Corp (IART) | Former Executive Vice President and Chief Financial Officer | $466,346 | $2,060,755 |